DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Sumycin (Tetracycline) - Description and Clinical Pharmacology



Sumycin for oral administration contains tetracycline, an antibiotic isolated from Streptomyces aureofaciens. Tetracycline is described chemically as 4-(dimethylamino)-1, 4, 4a, 5, 5a, 6, 11, 12a-octahydro-3, 6, 10, 12, 12a-pentahydroxy-6-methyl-1, 11-dioxo-2-napthacenecarboxamide; its structural formula is:

C22H24N2O8 MW=444.44

Sumycin Syrup (Tetracycline Oral Suspension, USP) is a suspension containing, in each 5 mL teaspoonful, tetracycline equivalent to 125 mg tetracycline hydrochloride. Inactive ingredients: citric acid, colorant (D&C Yellow No. 10), flavor, potassium citrate, potassium metaphosphate, purified water, saccharin sodium, sodium benzoate, sodium citrate, sodium metabisulfite, sorbitol solution, sucrose, and tragacanth.


Tetracyclines are adequately but incompletely absorbed from the gastrointestinal tract. Approximately 65 percent of a short-acting tetracycline is bound to plasma proteins; the plasma protein binding for intermediate- and long-acting analogues is usually greater.

Penetration of the tetracyclines into most body fluids and tissues is excellent. Tetracyclines are distributed in varying degrees into bile, liver, lung, kidney, prostate, urine, cerebrospinal fluid, synovial fluid, mucosa of the maxillary sinus, brain, sputum, and bone. Tetracyclines cross the placenta and enter the fetal circulation and amniotic fluid.

Following a single oral dose, peak plasma concentrations are achieved in two to four hours.

Tetracyclines are concentrated by the liver in the bile. They are excreted in both the urine and feces at high concentrations in a biologically active form. Since renal clearance of tetracyclines is by glomerular filtration, excretion is significantly affected by the state of renal function. (See WARNINGS.)


The tetracyclines are primarily bacteriostatic and are thought to exert their antimicrobial effect by the inhibition of protein synthesis. The tetracyclines have a similar antimicrobial spectrum of activity against a wide range of gram-positive and gram-negative organisms. Cross-resistance of these organisms to tetracyclines is common. In addition, gram-negative bacilli made tetracycline-resistant, may also show cross-resistance to chloramphenicol.


Bartonella bacilliformis

Brucella species

Calymmatobacterium granulomatis

Campylobacter fetus

Francisella tularensis

Haemophilus ducreyi

Haemophilus influenzae

Listeria monocytogenes

Neisseria gonorrhoeae

Vibrio cholerae

Yersinia pestis

Because many strains of the following groups of gram-negative microorganisms have been shown to be resistant to tetracyclines, culture and susceptibility testing are especially recommended:

Acinetobacter species

Bacteroides species

Enterobacter aerogenes

Escherichia coli

Klebsiella species

Shigella species


Enterococcus group [ Enterococcus faecalis (formerly Streptococcus faecalis) and Enterococcus

faecium (formerly Streptococcus faecium)]

Streptococci viridans group

Streptococcus pneumoniae

Streptococcus pyogenes

Because many strains of these gram-positive microorganisms have been shown to be resistant to tetracycline, culture and susceptibility testing are recommended. Up to 44 percent of strains of Streptococcus pyogenes and 74 percent of Enterococcus faecalis (formerly Streptococcus faecalis) have been found to be resistant to tetracycline drugs. Therefore, tetracyclines should not be used for treatment of streptococcal disease unless the organism is known to be susceptible.


Actinomyces species

Bacillus anthracis

Balantidium coli

Borrelia recurrentis

Chlamydia psittaci

Chlamydia trachomatis

Clostridium species

Entamoeba species

Fusobacterium fusiforme

Mycoplasma pneumoniae


Propionibacterium acnes

Treponema pallidum

Treponema pertenue

Ureaplasma urealyticum

Susceptibility Tests


Quantitative methods that require measurement of zone diameters give the most precise estimate of the susceptibility of bacteria to antimicrobial agents. One such standard procedure1 that has been recommended for use with disks to test susceptibility of microorganisms to tetracycline uses the 30-mcg tetracycline disk. Interpretation involves the correlation of the zone diameters obtained in the disk test with the minimum inhibitory concentration (MIC) for tetracycline.

Reports from the laboratory giving results of the standard single-disk susceptibility test with a 30-mcg tetracycline disk should be interpreted according to the following criteria:

Zone diameter (mm) Interpretation
≥ 19Susceptible
15 – 18Intermediate
≤ 14Resistant

A report of “Susceptible” indicates that the pathogen is likely to be inhibited by generally achievableblood levels. A report of “Intermediate” suggests that the organism would be susceptible if high dosage isused or if the infection is confined to tissues or fluids in which high antibiotic (or antimicrobial) levels are attained. A report of “Resistant” indicates that achievable concentrations are unlikely to be inhibitory and other therapy should be selected.

Standardized procedures require the use of laboratory control organisms. The 30-mcg tetracycline disk should give the following zone diameters:

Organism - Zone Diameter (mm)
E. coli ATCC2592218 – 25
S. aureus ATCC2592319 - 18


Use a standardized dilution method2 (broth, agar, microdilution) or equivalent with tetracycline powder. The MIC values obtained should be interpreted according to the following criteria:

MIC (mcg/mL) Interpretation
≤ 4.0Susceptible
> 4.0 < 16Intermediate
≥ 16Resistant

As with standard diffusion techniques, dilution methods require the use of laboratory control organisms. Standard tetracycline powder should provide the following MIC values:

Organism - Zone Diameter (mm)
E. coli ATCC259221 – 4
S. aureus ATCC292130.25 – 1
E. faecalis ATCC292128 – 32
P. aeruginosa ATCC278538 - 32


Hyperpigmentation of the thyroid has been produced by members of the tetracycline class in the following species: in rats by oxytetracycline, doxycycline, tetracycline PO4 and methacycline; in minipigs by doxycycline, minocycline, tetracycline PO4 and methacycline; in dogs by doxycycline and minocycline; in monkeys by minocycline.

Minocycline, tetracycline PO4, methacycline, doxycycline, tetracycline base, oxytetracycline HCl and tetracycline HCl were goitrogenic in rats fed a low iodine diet. This goitrogenic effect was accompanied by high radioactive iodine uptake. Administration of minocycline also produced a large goiter with high radioiodine uptake in rats fed a relatively high iodine diet.

Treatment of various animal species with this class of drugs has also resulted in the induction of thyroid hyperplasia in the following: in rats and dogs (minocycline), in chickens (chlortetracycline), and in rats and mice (oxytetracycline). Adrenal gland hyperplasia has been observed in goats and rats treated with oxytetracycline.

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017